ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Astal Laboratories converted 1,13,300 warrants into equity shares. Additionally, 1,86,700 warrants lapsed and were forfeited by the company during the quarter.
Astal Laboratories forfeited ₹0.19 Crore after 1,86,700 convertible warrants lapsed without being exercised. The warrants expired on May 26, 2026, after an 18-month conversion period.
Astal Laboratories allotted 1,13,300 equity shares upon warrant conversion, raising Rs. 0.45 Crore. This conversion by non-promoters increases the company's total paid-up equity capital.
Astal Laboratories allotted 14,70,000 equity shares following warrant conversions, raising ₹5.88 Crore. The allotment increases paid-up capital and expands the non-promoter equity base.